-+ 0.00%
-+ 0.00%
-+ 0.00%

CORBUS PHARMACEUTICALS HOLDINGS, - CRB-913 TREATMENT DISCONTINUATIONS DUE TO ADVERSE EVENTS RANGE FROM 3.1% TO 13.1%

Reuters·09/14/2026 11:00:04

Please log in to view news